1. Home
  2. GKOS vs COMP Comparison

GKOS vs COMP Comparison

Compare GKOS & COMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$107.89

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Compass Inc.

COMP

Compass Inc.

HOLD

Current Price

$10.42

Market Cap

4.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
COMP
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.9B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
GKOS
COMP
Price
$107.89
$10.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
9
Target Price
$122.08
$10.39
AVG Volume (30 Days)
1.1M
12.9M
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$469,820,000.00
$6,642,200,000.00
Revenue This Year
$30.89
$25.14
Revenue Next Year
$24.36
$12.29
P/E Ratio
N/A
N/A
Revenue Growth
30.38
24.27
52 Week Low
$73.16
$5.10
52 Week High
$163.71
$11.03

Technical Indicators

Market Signals
Indicator
GKOS
COMP
Relative Strength Index (RSI) 73.56 72.26
Support Level $104.11 $10.15
Resistance Level $107.18 $11.03
Average True Range (ATR) 4.40 0.42
MACD 1.26 0.06
Stochastic Oscillator 92.97 70.95

Price Performance

Historical Comparison
GKOS
COMP

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

Share on Social Networks: